Vagelos P Roy - Aug 25, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Stock symbol
REGN
Transactions as of
Aug 25, 2021
Transactions value $
-$19,455,564
Form type
4
Date filed
8/27/2021, 04:01 PM
Previous filing
Aug 19, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $13.4M +75K +25.77% $179.13* 366K Aug 25, 2021 Direct
transaction REGN Common Stock Tax liability -$32.9M -49.3K -13.46% $667.39 317K Aug 25, 2021 Direct
holding REGN Common Stock 2.22K Aug 25, 2021 By 401(k) Plan
holding REGN Common Stock 142K Aug 25, 2021 by CLAT
holding REGN Common Stock 37.7K Aug 25, 2021 by Spouse as Trustee
holding REGN Common Stock 3.61K Aug 25, 2021 by trust for grandch F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -75K -50% $0.00 75K Aug 25, 2021 Common Stock 75K $179.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.